Skip to navigation Skip to content

Clinical Trial: Ocrelizumab

Share

Details
Type of MS: RRMS|SPMS
Treatment mode of action: To affect immune function
Number of Subjects: 3
Medication: ocrelizumab
Location: Colorado
Institutions: Advanced Neurosciences Research of Colorado Contact Information
Paul Miller,Sylvia Akmakjian,Lillie Denny
(970) 226-6111
pmmiller1@aol.com

Funding:

F. Hoffman-La Roche Ltd

Description

An open-label, single-arm study to evaluate the effectiveness and safety of ocrelizumab in patients with early stage relapsing remitting multiple sclerosis.

Share